Back to Results
First PageMeta Content
PARP inhibitor / Autoimmune diseases / Olaparib / Poly ADP ribose polymerase / Ankylosing spondylitis / TNF inhibitor / Targeted therapy / Non-steroidal anti-inflammatory drug / Disease-modifying antirheumatic drug / Medicine / Biology / Pharmacology


March[removed]Making a difference with chemistry You may enjoy studying chemistry, but how can you use it to make a difference
Add to Reading List

Document Date: 2015-03-05 09:09:56


Open Document

File Size: 1,26 MB

Share Result on Facebook

Company

ADP / /

Country

United Kingdom / /

Facility

University of Sheffield / Helleday laboratory / National Institute / /

IndustryTerm

online archives / /

MedicalCondition

breast cancers / cancer / tumour necrosis / disease / ankylosing spondylitis / chronic inflammatory conditions / further inflammation / chronic inflammatory disease / pain / inflammatory cascade / breast cancer / /

Organization

University of Sheffield / European Medicines Agency / US Federal Reserve / National Institute for Health and Core Excellence / United States Food and Drug Administration / /

Person

Andreas / Helen Bryant / Isaac Bruce / /

Position

lead author / head / /

Product

adenosine / /

ProvinceOrState

Yorkshire / /

URL

www.helleday.org/parp-brcastory.html / www.hoddereducation.co.uk/magazines / /

SocialTag